Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als symbols : SNYNF save search
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Published: 2024-04-15 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
drug als biomarker
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Published: 2024-04-03 (Crawled : 16:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
health als granted canada
ALS Treatment Landscape ‘Primed’ with Over 100 Candidates: GlobalData
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
als treatment 100
Sanofi, Denali ALS Candidate Flops in Mid-Stage Trial
Published: 2024-02-19 (Crawled : 13:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
candidate als trial
$350M Funding Breaths New Life into Former ALS Compound for Asthma
Published: 2022-07-12 (Crawled : 15:20) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
life als funding
Denali/Sanofi ALS Candidate Hits Phase II as Awareness Month Begins
Published: 2022-05-03 (Crawled : 15:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
als
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Published: 2022-05-02 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -2.05%
H: 0.0%
C: 0.0%
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: -6.34%
H: 6.77%
C: 6.48%
als trial therapeutics sanofi milestone phase 2
Global Generic Injectables Market Research Report 2022: Expiration of Branded Drug Patents & Rising Approvals for Generic Injectable Drugs
Published: 2022-03-15 (Crawled : 23:00) - prnewswire.com
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.87%
H: 0.27%
C: -0.51%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
als drug patent research approval report
Avadel Pharmaceuticals Announces Appointment of Brandi Robinson as Senior Vice President, Corporate Affairs
Published: 2022-03-14 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -3.03%
H: 3.21%
C: 3.21%
RFL 4 | $1.71 -3.93% 0.0% 11K
|
Finance
|
| O: 0.48%
H: 4.27%
C: -0.47%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: 0.0%
AVDL | $17.4 -3.28% -3.39% 1.1M
|
Health Technology
|
| O: -10.18%
H: 4.38%
C: 4.08%
als ces air
Imbria Pharmaceuticals Strengthens Executive Leadership Team with New Appointments
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.52%
H: 1.67%
C: 1.67%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
als
Long term study confirms efficacy of ISA Pharmaceuticals' T-cell activating immunotherapy in combination with checkpoint inhibitor
Published: 2022-03-01 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
als long term cel immunotherapy therapy t-cell
Pause of GSK's RSV Vaccine Trials in Pregnant Women Deepens
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
als trials trial women vaccine
Rhythm Pharmaceuticals Announces Promotions within its Executive Leadership Team
Published: 2022-02-23 (Crawled : 13:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.09%
H: 0.08%
C: -1.22%
RYTM A | $38.11 -0.88% -0.89% 440K
|
Health Technology
|
| O: 0.24%
H: 3.81%
C: -0.24%
als ces
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Published: 2022-02-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
als ces new ceo ceo
Global Roundup: Genuv Adds AI to Aid Discovery of Alzheimer's, ALS Therapies
Published: 2022-02-17 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.23%
TRIB | $1.83 -0.54% -0.55% 23K
|
Health Technology
|
| O: 0.88%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.4%
H: 0.76%
C: 0.17%
OPT | $3.41 0.29% 0.29% 2.7K
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
ACIU | $2.38 -1.65% 0.41% 370K
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: -2.19%
alzheimer als alzheimer’s therapy alzheimer's
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Period Activity
Published: 2022-02-10 (Crawled : 13:30) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.66%
H: 6.03%
C: 1.83%
als financial results report results
Worldwide Hospital Services Industry to 2027 - Rising Investment in Healthcare Infrastructure and Professionals Presents Opportunities
Published: 2022-01-14 (Crawled : 12:30) - prnewswire.com
THC | $91.08 -5.13% -0.09% 2.3M
|
Health Services
|
| O: 1.58%
H: 0.0%
C: 0.0%
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
PHG | $19.98 -0.84% 0.0% 500K
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
GE | $152.94 -1.75% 0.0% 6M
|
Electronic Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
CYH | $2.78 -4.47% 0.0% 2.1M
|
Health Services
|
| O: 1.09%
H: 0.0%
C: 0.0%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
A | $132.44 -1.57% -0.36% 1.9M
|
Health Technology
|
| O: -3.36%
H: 0.0%
C: 0.0%
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
|
| O: -0.09%
H: 0.0%
C: -1.17%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
health als ces thc services
Global Big Pharma Partnering Deals Directory 2021
Published: 2022-01-12 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
als deal pharma
Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO
Published: 2022-01-05 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
CERS | News | $1.645 0.31% 0.3% 760K
|
Health Technology
|
| O: -1.06%
H: 1.23%
C: -4.6%
als ceo
Crinetics Pharmaceuticals Adds Board Member with Global Rare Disease Expertise with Appointment of Rogério Vivaldi Coelho, M.D., M.B.A.
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
CRNX | $43.005 -2.28% -2.34% 540K
|
Health Technology
|
| O: -0.57%
H: 1.86%
C: -2.46%
als disease rare
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.